SteelPeak Wealth LLC Invests $1.05 Million in DaVita Inc. (NYSE:DVA)

SteelPeak Wealth LLC bought a new stake in DaVita Inc. (NYSE:DVA) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 6,987 shares of the company’s stock, valued at approximately $1,045,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. MML Investors Services LLC raised its position in DaVita by 1.3% during the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after purchasing an additional 68 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in shares of DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after purchasing an additional 68 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of DaVita by 1.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock worth $776,000 after buying an additional 70 shares in the last quarter. Impact Partnership Wealth LLC lifted its position in shares of DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after buying an additional 70 shares during the last quarter. Finally, Contravisory Investment Management Inc. boosted its stake in DaVita by 1.2% in the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after buying an additional 73 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 0.3 %

NYSE:DVA opened at $173.80 on Thursday. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. DaVita Inc. has a one year low of $107.44 and a one year high of $178.75. The firm’s 50 day simple moving average is $159.25 and its 200 day simple moving average is $154.62. The company has a market cap of $14.25 billion, a PE ratio of 18.75, a P/E/G ratio of 0.82 and a beta of 0.92.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.85 EPS. On average, research analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Barclays boosted their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial increased their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $161.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.